OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Citicoline in the Management of Traumatic Brain Injury
Julio J Secades
Pharmaceuticals (2021) Vol. 14, Iss. 5, pp. 410-410
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Pathophysiology-Based Management of Secondary Injuries and Insults in TBI
Leonardo de Macêdo Filho, Luisa Figueredo, Gustavo Adolfo Villegas-Gomez, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 520-520
Open Access | Times Cited: 11

Inflammatory response in traumatic brain and spinal cord injury: The role of XCL1‐XCR1 axis and T cells
Mingkang Zhang, Xiaonan Han, Liyan Yan, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 6
Open Access | Times Cited: 8

Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities
Sana Javaid, Talha Bin Farooq, Zohabia Rehman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 21, pp. 11313-11313
Open Access | Times Cited: 43

Unveiling citicoline's mechanisms and clinical relevance in the treatment of neuroinflammatory disorders
Simona Cavalu, Sameh Saber, Asmaa Ramadan, et al.
The FASEB Journal (2024) Vol. 38, Iss. 17
Open Access | Times Cited: 4

Citicoline for the Management of Patients with Traumatic Brain Injury in the Acute Phase: A Systematic Review and Meta-Analysis
Julio J Secades, Helmut Trimmel, Byron Salazar, et al.
Life (2023) Vol. 13, Iss. 2, pp. 369-369
Open Access | Times Cited: 9

Citicoline and COVID-19: vis-à-vis conjectured
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15

Mitigating Traumatic Brain Injury: A Narrative Review of Supplementation and Dietary Protocols
Federica Conti, JACKSON MCCUE, Paul DiTuro, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2430-2430
Open Access | Times Cited: 2

Traumatic brain injury: Advances in coagulopathy (Review)
Hongqiao Hou, Zhe Qu, Ruping Liu, et al.
Biomedical Reports (2024) Vol. 21, Iss. 5
Open Access | Times Cited: 2

CDP-choline to promote remyelination in multiple sclerosis: the need for a clinical trial
Viktoria Gudi, Paweł Grieb, Ralf A. Linker, et al.
Neural Regeneration Research (2023) Vol. 18, Iss. 12, pp. 2599-2605
Open Access | Times Cited: 6

Traumatic Brain Injury and Immunological Outcomes: the double-edged Killer
Souvik Datta, Feng Lin, L. Jones, et al.
Future Science OA (2023) Vol. 9, Iss. 6
Open Access | Times Cited: 4

Citicoline in neurology and psychiatry
Aleksandra Pavlović, Dragan Pavlović, S. Totić, et al.
Engrami (2024), Iss. 00, pp. 7-7
Open Access | Times Cited: 1

Preclinical evidence for the anxiolytic- and antidepressant-like effects of citicoline and imipramine in the sciatic nerve-ligated mice
Mohammad‐Reza Zarrindast, Bardia Hajikarimloo, Nastaran Raissi-Dehkordi, et al.
IBRO Neuroscience Reports (2024) Vol. 17, pp. 364-371
Open Access | Times Cited: 1

Identification of difluorinated curcumin molecular targets linked to traumatic brain injury pathophysiology
Amirhossein Sahebkar, Thozhukat Sathyapalan, Paul C. Guest, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 148, pp. 112770-112770
Open Access | Times Cited: 7

Ten good reasons to consider gastrointestinal function after acute brain injury
Silvia De Rosa, Denise Battaglini, Juan Antonio Llompart‐Pou, et al.
Journal of Clinical Monitoring and Computing (2023) Vol. 38, Iss. 2, pp. 355-362
Closed Access | Times Cited: 3

The Role of P2Y6 Receptors in the Mechanisms of the Neuroprotective Effect of Citicoline
Г. З. Суфианова, А. Г. Шапкин, Maria S. Khlestkina, et al.
Bulletin of Experimental Biology and Medicine (2023) Vol. 175, Iss. 1, pp. 45-48
Closed Access | Times Cited: 2

Pathophysiology-Based Management of Secondary Injuries and Insults in TBI
Leonardo de Macêdo Filho, Luisa Figueredo, Maria Camila Pedraza‐Ciro, et al.
(2023)
Open Access | Times Cited: 2

A novel pharmacological treatment concept for neuroprotection in severe traumatic brain injury—Two case reports
Helmut Trimmel, Guenther Herzer, Christoph Derdak, et al.
Clinical Case Reports (2022) Vol. 10, Iss. 11
Open Access | Times Cited: 4

An Overview of Combination Treatment with Citicoline in Dementia
Pietro Gareri, Nicola Veronese, Antonino Maria Cotroneo
Reviews on Recent Clinical Trials (2021) Vol. 17, Iss. 1, pp. 4-8
Closed Access | Times Cited: 4

Peran Citicoline Oral Sebagai Terapi Tambahan dalam Pengobatan Glaukoma
Wina Sinaga
Cermin Dunia Kedokteran (2024) Vol. 51, Iss. 3, pp. 168-172
Open Access

The Role of Citicoline in Post-Brain Surgery Children
Lina Purnamasari
Cermin Dunia Kedokteran (2024) Vol. 51, Iss. 5, pp. 275-279
Open Access

Cytoprotection as an Innovative Therapeutic Strategy to Cardiogenic Shock: Exploring the Potential of Cytidine-5-Diphosphocholine to Mitigate Target Organ Damage
Héctor González‐Pacheco, Luis Manuel Amezcua-Guerra, Martha Franco, et al.
Journal of Vascular Research (2024) Vol. 61, Iss. 4, pp. 160-165
Closed Access

Combined irradiation by gamma-rays and carbon-12 nuclei caused hyperlocomotion and change in striatal metabolism of rats
В. С. Кохан, Kirill Chaprov, Д. А. Абаимов, et al.
Life Sciences in Space Research (2024) Vol. 44, pp. 99-107
Closed Access

Application of Choline for Treatment of Traumatic Brain Injury
Fatima Rachidi, Hajar Ouaki, Rabii Hilali, et al.
(2024), pp. 151-165
Closed Access

Citicoline on the Barthel Index: Severe and moderate brain injury
Mehdi Mahmoodkhani, Bahram Aminmansour, Mehdi Shafiei, et al.
Indian Journal of Pharmacology (2023) Vol. 55, Iss. 4, pp. 223-228
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top